BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aksys (AKSY) To Announce Third Quarter 2006 Results On November 13, 2006


11/8/2006 11:25:23 AM

LINCOLNSHIRE, Ill., Nov. 7 /PRNewswire-FirstCall/ -- Aksys(R), Ltd. , a pioneer in innovative dialysis systems, announced plans to release its financial results for the third quarter ended September 30, 2006 on Monday, November 13, 2006 before the opening of the financial markets.

Aksys will also host a conference call at 1:00 p.m. Central Time on November 13, 2006 to discuss the third quarter 2006 results. To listen to the conference call, please dial (866) 238-0637 for domestic callers and (703) 639-1156 for international callers. The passcode is 994727. A live webcast of the conference call can be accessed at http://www.aksys.com/invest/.

An archived replay of the conference call will be available from 4:00 p.m. CT, Monday, November 13 through 6:00 p.m. CT Monday, November 27 by dialing 703-925-2533 code 994727. The archived replay of the webcast will also be available until November 27th at http://www.aksys.com/invest/ .

About the Company

Aksys, Ltd., designs, develops, and markets innovative hemodialysis products and services for patients suffering from kidney failure. The Company's next-generation system, known as the G-2 system, is being designed to leverage the safety record, ease-of-use, and clinical benefits provided by the original PHD System, while significantly improving reliability and lowering costs. Patients with ESRD who dialyze at home benefit from improved quality of life, reduced mortality, and morbidity while reducing the associated high cost of in-hospital or in-clinic patient care. Further information is available on Aksys' website: http://www.aksys.com/ .

Aksys(R), Ltd.

CONTACT: Juliane Snowden-Andrew, Investors, jsnowden-andrew@burnsmc.com,or Justin Jackson, Media, jjackson@burnsmc.com, all of Burns McClellan,Inc., +1-212-213-0006



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES